Category: AIDS, HIV & STDs
Global AIDS, HIV & STDs
-
Global Drug of Abuse Testing Market (By Product Type, Sample / Test Type, Drug Type, End Users / Setting Type, Country Analysis), Regulatory Status, Recent Developments, Company Profiles - Forecast to 2032
... of abuse testing market was valued at US$ 6,973 Million in 2023, and is predicted to reach US$ 11,715 Million by 2032. The use of illicit drugs is increasing across the globe. An estimated 296 ... Read More
-
Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029
... market trends is crucial for healthcare providers, investors, and industry stakeholders. This report offers a detailed analysis of the factors driving growth, including the increasing recognition of infectious diseases as a global health concern. As ... Read More
-
Global Herpes Zoster Therapeutics Market 2024-2028
... period. The report on the herpes zoster therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
2024-2029 Global Sexually-Transmitted Diseases (STD) Market for AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, and Trichomonas Vaginalis Tests: US, Europe, Japan - Suppli
... Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities This new report from LeadingMarketResearch.com provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles ... Read More
-
Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living with HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029
... The latent TB testing market will rise in value from estimated USD 582.5 million in 2024 to USD 773.4 million in 2029, at a CAGR of 5.8% over the forecast period. Increased funding and grants ... Read More
-
STD Testing
... at a CAGR of 5.2% over the analysis period 2023-2030. Chlamydia Testing, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of ... Read More
-
Herpes Zoster (Shingles) - Global Clinical Trials Review, 2024
... provides top line data relating to the clinical trials on Herpes Zoster (Shingles). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage ... Read More
-
Herpes Zoste Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application
... from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price is presented from 2019 ... Read More
-
Global Sexually Transmitted Diseases (STD) Treatment Market 2024-2028
... report on the sexually transmitted diseases (Std) treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
2024-2028 Global Herpes Testing (Simplex I/II, Type VI) in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Regions and Countries Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, ... Read More
-
Herpes Marker Testing
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$279.9 Million ... Read More
-
C-X-C Chemokine Receptor 4 (CXCR4) Antagonists Global Market Report 2024 Including: 1) By Type: BL-8040; GMI-1359; Plerixafor (AMD3100); Balixafortide (POL6326); USL311; Burixafor (GPC-100) 2) By Route Of Administration: Oral; Injectable 3) By Product Pipeline: Approved; Clinical Trials; Pre-Clinical 4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies Covering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers Squibb Company; AstraZeneca plc
... Pre-Clinical4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers ... Read More
-
Chlamydia Infection Treatment Global Market Report 2024 Including: 1) By Treatment: Chlamydia Culture; Urine Culture; Enzyme Immunoassays; Nucleic Acid Amplification Test 2) By Causative Organisms: Chlamydia Trachomatis; Chlamydophila Pneumoniae 3) By Route Of Administration: Oral; Injectables 4) By End-Users: Hospitals; Homecare; Specialty Clinics Covering: Pfizer Inc.; F. Hoffmann La-Roche Ltd; Merck & Co. Inc.; AbbVie Inc; Sanofi S.A.
... End-Users: Hospitals; Homecare; Specialty Clinics Covering: Pfizer Inc.; F. Hoffmann La-Roche Ltd; Merck & Co. Inc.; AbbVie Inc; Sanofi S.A. Chlamydia Infection Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers ... Read More
-
Global Herpes Marker Testing Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Herpes Marker Testing is forecast to a readjusted size of US$ 92 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential ... Read More
-
Global Herpes Zoster Infection Treatment Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Herpes Zoster Infection Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Treatment and Prevention of Herpes Labialis Market Growth (Status and Outlook) 2024-2030
... 1168.4 million in 2023. With growing demand in downstream market, the Treatment and Prevention of Herpes Labialis is forecast to a readjusted size of US$ 1574.9 million by 2030 with a CAGR of 4.4% during ... Read More
-
Global Sexually Transmitted Disease (STD) Testing Market 2024-2028
... report on the sexually transmitted disease (STD) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Genital Herpes Global Market Report 2024
... ; AbbVie Inc.; Sanofi SA Genital Herpes Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses ... Read More
-
Global Human Anti-Herpes Simplex Virus Type 1 ELISA Kit Market Growth 2024-2030
... US$ million in 2023. With growing demand in downstream market, the Human Anti-Herpes Simplex Virus Type 1 ELISA Kit is forecast to a readjusted size of US$ million by 2030 with a CAGR of % ... Read More
-
Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market Growth 2024-2030
... US$ million in 2023. With growing demand in downstream market, the Human Anti-Herpes Simplex Virus Type 2 ELISA Kit is forecast to a readjusted size of US$ million by 2030 with a CAGR of % ... Read More
-
2024 Global Sexually-Transmitted Disease (STD) Testing Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Country - Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis
... and provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. Please note: The delivery time for the electronic ... Read More
-
2024 Global Chlamydia Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
-
2024 Global HIV/AIDS Diagnostics Market: US, Europe, Japan - Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5-year test volume and ... Read More
-
2024 Global Gonorrhea Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Gonorrhea definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
-
2024 Global Syphilis Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Syphilis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
Research Assistance
